Recently, Zhejiang Conba Pharmaceutical Co., Ltd. announced that Mr. Jin Zucheng, Vice President of the company, has officially resigned due to reaching the statutory retirement age. According to the announcement, Mr. Jin’s resignation took effect in June 2024. During his tenure, he diligently fulfilled his responsibilities and made significant contributions to the company’s strategic development, product innovation, and market expansion. Conba expressed sincere gratitude for Mr. Jin’s years of dedication and extended best wishes for a happy and healthy retirement.Since joining Conba, Mr. Jin has accumulated extensive experience in pharmaceutical enterprise management, R&D strategy, and compliance operations. His departure is part of a routine leadership transition and is not expected to significantly impact the company’s daily operations or management. Conba has already initiated succession planning to ensure a smooth transition. As a well-known integrated pharmaceutical company specializing in both traditional Chinese medicine and chemical drugs, Conba has been actively advancing its transformation, strengthening technological innovation, and expanding its global footprint. This executive change also reflects the company’s well-structured talent pipeline and sustainable leadership development.Industry analysts note that as regulatory scrutiny intensifies and competition grows in the pharmaceutical sector, stable and seamless executive succession is crucial. Conba’s smooth leadership handover demonstrates the maturity of its corporate governance and enhanced institutional capabilities.
近日，浙江康恩贝制药股份有限公司发布公告称，公司副总裁金祖成先生因达到法定退休年龄，正式辞去公司副总裁职务。根据公告，金祖成先生的辞职自2024年6月起生效，其在任职期间勤勉尽责，为公司战略发展、产品创新及市场拓展作出了重要贡献。康恩贝方面对金祖成先生多年来的辛勤付出表示衷心感谢，并祝愿其退休生活幸福安康。金祖成先生自加入康恩贝以来，长期深耕医药行业，在企业管理、研发战略和合规运营等方面积累了丰富经验。他的离任属于正常人事更替，不会对公司日常经营和管理造成重大影响。目前，康恩贝已启动相关岗位的接任安排，确保业务平稳过渡。作为国内知名的中药与化学药综合制药企业，康恩贝近年来持续推进转型升级，强化科技创新与国际化布局。此次高管变动也反映出公司人才梯队建设的有序性和可持续性。业内分析人士指出，随着医药行业监管趋严与竞争加剧，企业高层管理团队的稳定与传承尤为重要。康恩贝此次平稳完成高管交接，体现了其治理结构的成熟与制度化水平的提升。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/7927.html